| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophils | 167 | 2024 | 950 | 20.850 |
Why?
|
| Secretory Vesicles | 14 | 2020 | 128 | 3.490 |
Why?
|
| Eosinophilia | 34 | 2024 | 560 | 3.130 |
Why?
|
| Hypereosinophilic Syndrome | 21 | 2024 | 97 | 2.990 |
Why?
|
| Cell Degranulation | 15 | 2024 | 277 | 2.230 |
Why?
|
| Lipid Metabolism | 27 | 2017 | 1902 | 2.060 |
Why?
|
| Leukocytes | 14 | 2016 | 2026 | 1.970 |
Why?
|
| Galectins | 4 | 2021 | 295 | 1.750 |
Why?
|
| Eicosanoids | 15 | 2017 | 282 | 1.670 |
Why?
|
| Leukotriene C4 | 11 | 2019 | 79 | 1.400 |
Why?
|
| Organelles | 8 | 2013 | 266 | 1.400 |
Why?
|
| Cytoplasmic Granules | 17 | 2017 | 574 | 1.400 |
Why?
|
| Chemokine CCL11 | 17 | 2018 | 128 | 1.390 |
Why?
|
| Inclusion Bodies | 14 | 2011 | 281 | 1.300 |
Why?
|
| Interleukin-4 | 14 | 2015 | 1149 | 1.200 |
Why?
|
| Cytokines | 28 | 2019 | 7396 | 1.190 |
Why?
|
| Microscopy, Electron | 16 | 2014 | 2561 | 1.150 |
Why?
|
| Lysophospholipase | 15 | 2020 | 66 | 1.120 |
Why?
|
| Churg-Strauss Syndrome | 8 | 2022 | 75 | 1.060 |
Why?
|
| Eosinophil Cationic Protein | 2 | 2018 | 9 | 1.000 |
Why?
|
| Arachidonic Acids | 16 | 2001 | 294 | 0.980 |
Why?
|
| Lipids | 13 | 2019 | 3341 | 0.940 |
Why?
|
| Ribonucleases | 7 | 2013 | 277 | 0.940 |
Why?
|
| Microscopy, Immunoelectron | 13 | 2016 | 317 | 0.930 |
Why?
|
| Leukotrienes | 5 | 2010 | 231 | 0.910 |
Why?
|
| Inflammation | 18 | 2019 | 10774 | 0.870 |
Why?
|
| Inflammation Mediators | 15 | 2017 | 1886 | 0.860 |
Why?
|
| Crystallization | 9 | 2019 | 534 | 0.830 |
Why?
|
| Cell Death | 5 | 2021 | 1679 | 0.830 |
Why?
|
| Receptors, Leukotriene | 4 | 2010 | 95 | 0.780 |
Why?
|
| Hypersensitivity | 9 | 2020 | 1171 | 0.750 |
Why?
|
| Interleukin-5 | 17 | 2018 | 269 | 0.740 |
Why?
|
| Brugia | 11 | 1992 | 24 | 0.720 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2013 | 615 | 0.720 |
Why?
|
| Chemokine CCL5 | 9 | 2018 | 214 | 0.710 |
Why?
|
| Mast Cells | 11 | 2014 | 1392 | 0.700 |
Why?
|
| Histocompatibility Antigens Class II | 5 | 2011 | 1435 | 0.670 |
Why?
|
| Cell Separation | 7 | 2014 | 1720 | 0.670 |
Why?
|
| Chemokines, CC | 11 | 2006 | 283 | 0.670 |
Why?
|
| Eosinophil Major Basic Protein | 5 | 2018 | 14 | 0.660 |
Why?
|
| Eosinophil Granule Proteins | 8 | 2021 | 29 | 0.650 |
Why?
|
| Receptors, CCR3 | 9 | 2018 | 62 | 0.630 |
Why?
|
| Receptors, Chemokine | 7 | 2006 | 652 | 0.620 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2018 | 162 | 0.600 |
Why?
|
| Arachidonic Acid | 15 | 2016 | 427 | 0.590 |
Why?
|
| Th2 Cells | 5 | 2015 | 1060 | 0.590 |
Why?
|
| Receptors, CCR7 | 2 | 2017 | 107 | 0.560 |
Why?
|
| rho-Associated Kinases | 1 | 2018 | 281 | 0.560 |
Why?
|
| Interleukin-16 | 7 | 2002 | 34 | 0.550 |
Why?
|
| Neutrophils | 21 | 2024 | 3767 | 0.550 |
Why?
|
| Cysteine | 3 | 2010 | 891 | 0.540 |
Why?
|
| Chemotaxis | 2 | 2017 | 598 | 0.530 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 10 | 2002 | 318 | 0.520 |
Why?
|
| Glycoproteins | 10 | 2020 | 2203 | 0.520 |
Why?
|
| Transport Vesicles | 4 | 2010 | 81 | 0.510 |
Why?
|
| Tissue Embedding | 1 | 2014 | 42 | 0.480 |
Why?
|
| Immunity, Innate | 4 | 2017 | 3066 | 0.470 |
Why?
|
| Pulmonary Eosinophilia | 3 | 2012 | 78 | 0.470 |
Why?
|
| Humans | 252 | 2024 | 761596 | 0.470 |
Why?
|
| Sepharose | 4 | 2005 | 103 | 0.460 |
Why?
|
| Microscopy, Electron, Transmission | 8 | 2022 | 695 | 0.460 |
Why?
|
| Filariasis | 12 | 1990 | 26 | 0.450 |
Why?
|
| Lymphokines | 6 | 1997 | 927 | 0.450 |
Why?
|
| Electron Microscope Tomography | 1 | 2013 | 17 | 0.440 |
Why?
|
| Membrane Microdomains | 1 | 2014 | 206 | 0.430 |
Why?
|
| Cytoplasm | 11 | 2016 | 1510 | 0.430 |
Why?
|
| Integrins | 3 | 2013 | 834 | 0.430 |
Why?
|
| Animals | 103 | 2020 | 168475 | 0.420 |
Why?
|
| Antigen Presentation | 4 | 2010 | 1251 | 0.420 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 687 | 0.410 |
Why?
|
| Mastocytosis, Systemic | 1 | 2014 | 103 | 0.410 |
Why?
|
| Cell Compartmentation | 7 | 2014 | 384 | 0.400 |
Why?
|
| Granulocytes | 3 | 2012 | 551 | 0.390 |
Why?
|
| Helminthiasis | 5 | 2010 | 81 | 0.390 |
Why?
|
| Respiratory Hypersensitivity | 3 | 2011 | 273 | 0.390 |
Why?
|
| Thymoma | 1 | 2013 | 188 | 0.380 |
Why?
|
| Flow Cytometry | 13 | 2015 | 5870 | 0.380 |
Why?
|
| Phospholipases | 10 | 1990 | 75 | 0.370 |
Why?
|
| Detergents | 1 | 2011 | 236 | 0.370 |
Why?
|
| Immune System | 1 | 2016 | 796 | 0.370 |
Why?
|
| Fibrosis | 3 | 2015 | 2049 | 0.360 |
Why?
|
| Platelet Activating Factor | 8 | 2005 | 143 | 0.360 |
Why?
|
| Thymus Neoplasms | 1 | 2013 | 274 | 0.360 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2013 | 2865 | 0.360 |
Why?
|
| Immunohistochemistry | 23 | 2014 | 11076 | 0.350 |
Why?
|
| Fluorescent Antibody Technique | 8 | 2017 | 2467 | 0.350 |
Why?
|
| Cell Fractionation | 2 | 2009 | 251 | 0.350 |
Why?
|
| Receptors, Prostaglandin | 3 | 2019 | 53 | 0.350 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2010 | 59 | 0.340 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 2013 | 547 | 0.340 |
Why?
|
| Intracellular Membranes | 2 | 2013 | 389 | 0.330 |
Why?
|
| Rhinoplasty | 1 | 2013 | 238 | 0.330 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2010 | 104 | 0.330 |
Why?
|
| Thrombophilia | 1 | 2012 | 305 | 0.330 |
Why?
|
| Lymph Nodes | 2 | 2017 | 3465 | 0.320 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2009 | 299 | 0.320 |
Why?
|
| Myeloproliferative Disorders | 3 | 2010 | 613 | 0.320 |
Why?
|
| Anthelmintics | 3 | 2006 | 83 | 0.320 |
Why?
|
| Travel | 6 | 2001 | 796 | 0.320 |
Why?
|
| Cyclooxygenase Inhibitors | 3 | 2002 | 361 | 0.320 |
Why?
|
| Phospholipases A | 2 | 2001 | 204 | 0.320 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 5 | 2014 | 105 | 0.320 |
Why?
|
| Leukocyte Count | 8 | 2022 | 1596 | 0.320 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2009 | 3810 | 0.320 |
Why?
|
| Microscopy | 2 | 2011 | 903 | 0.320 |
Why?
|
| Intracellular Space | 2 | 2017 | 197 | 0.310 |
Why?
|
| Antigen-Presenting Cells | 2 | 2007 | 964 | 0.310 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2007 | 755 | 0.300 |
Why?
|
| Alum Compounds | 1 | 2008 | 32 | 0.300 |
Why?
|
| Tropical Medicine | 2 | 2017 | 51 | 0.300 |
Why?
|
| Filarioidea | 5 | 1990 | 9 | 0.300 |
Why?
|
| Chemotaxis, Leukocyte | 10 | 2005 | 662 | 0.300 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 10 | 2009 | 891 | 0.300 |
Why?
|
| Chemotactic Factors, Eosinophil | 4 | 2005 | 40 | 0.290 |
Why?
|
| Mice, Inbred BALB C | 8 | 2018 | 6214 | 0.290 |
Why?
|
| Cells, Cultured | 26 | 2018 | 18966 | 0.290 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 5 | 2014 | 368 | 0.290 |
Why?
|
| Asthma | 14 | 2017 | 6234 | 0.280 |
Why?
|
| Schistosoma mansoni | 4 | 2018 | 155 | 0.280 |
Why?
|
| Exocytosis | 4 | 2016 | 320 | 0.280 |
Why?
|
| Arachidonate 5-Lipoxygenase | 6 | 2005 | 128 | 0.280 |
Why?
|
| Signal Transduction | 17 | 2017 | 23447 | 0.270 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2011 | 4369 | 0.270 |
Why?
|
| Immunoglobulin M | 4 | 2008 | 1526 | 0.270 |
Why?
|
| Autocrine Communication | 4 | 2011 | 169 | 0.260 |
Why?
|
| Lymphocytes | 7 | 1997 | 2612 | 0.260 |
Why?
|
| Biological Assay | 2 | 2017 | 626 | 0.260 |
Why?
|
| SRS-A | 7 | 1989 | 132 | 0.260 |
Why?
|
| Receptors, Immunologic | 6 | 2019 | 1410 | 0.260 |
Why?
|
| Membrane Proteins | 10 | 2018 | 7859 | 0.260 |
Why?
|
| Tomography | 1 | 2008 | 411 | 0.250 |
Why?
|
| Microscopy, Fluorescence | 6 | 2017 | 2645 | 0.250 |
Why?
|
| Chemokine CCL19 | 2 | 2017 | 35 | 0.250 |
Why?
|
| Leishmaniasis, Mucocutaneous | 1 | 2005 | 14 | 0.250 |
Why?
|
| Anti-Asthmatic Agents | 4 | 2007 | 574 | 0.250 |
Why?
|
| Leishmania braziliensis | 1 | 2005 | 16 | 0.250 |
Why?
|
| Helminths | 3 | 2010 | 39 | 0.250 |
Why?
|
| Biological Transport | 5 | 2016 | 2091 | 0.250 |
Why?
|
| Subcellular Fractions | 8 | 2015 | 532 | 0.250 |
Why?
|
| Receptors, Cytokine | 1 | 2006 | 258 | 0.240 |
Why?
|
| Protein Transport | 6 | 2016 | 1967 | 0.240 |
Why?
|
| Chemotactic Factors | 3 | 1996 | 197 | 0.240 |
Why?
|
| Lung | 12 | 2017 | 10002 | 0.240 |
Why?
|
| U937 Cells | 2 | 2006 | 261 | 0.240 |
Why?
|
| Mice | 31 | 2019 | 81539 | 0.230 |
Why?
|
| Prednisone | 4 | 2022 | 1563 | 0.230 |
Why?
|
| Surgical Flaps | 1 | 2013 | 1671 | 0.230 |
Why?
|
| Basophils | 4 | 2001 | 407 | 0.230 |
Why?
|
| Cell Communication | 4 | 2014 | 1657 | 0.230 |
Why?
|
| HLA-DR Antigens | 5 | 1993 | 602 | 0.230 |
Why?
|
| Blotting, Western | 4 | 2013 | 5035 | 0.220 |
Why?
|
| Chemokines | 3 | 2007 | 959 | 0.220 |
Why?
|
| Wuchereria bancrofti | 9 | 2001 | 20 | 0.220 |
Why?
|
| Th1 Cells | 1 | 2008 | 1036 | 0.220 |
Why?
|
| Nitrobenzenes | 1 | 2002 | 66 | 0.210 |
Why?
|
| Chondro-4-Sulfatase | 5 | 1997 | 5 | 0.210 |
Why?
|
| Staining and Labeling | 5 | 2017 | 1085 | 0.210 |
Why?
|
| Extracellular Space | 3 | 2013 | 563 | 0.200 |
Why?
|
| Cell Movement | 12 | 2012 | 5205 | 0.200 |
Why?
|
| Skin Diseases | 5 | 2012 | 1094 | 0.200 |
Why?
|
| Prostaglandin D2 | 3 | 2018 | 108 | 0.200 |
Why?
|
| Leukotriene Antagonists | 4 | 2010 | 124 | 0.200 |
Why?
|
| Brefeldin A | 3 | 2008 | 68 | 0.200 |
Why?
|
| Mucus | 1 | 2024 | 341 | 0.190 |
Why?
|
| Fascioliasis | 1 | 2001 | 14 | 0.190 |
Why?
|
| Fasciola hepatica | 1 | 2001 | 15 | 0.190 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2013 | 4062 | 0.190 |
Why?
|
| Antigens, CD | 6 | 2009 | 4001 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 13 | 2013 | 10766 | 0.190 |
Why?
|
| Immunity | 3 | 2015 | 996 | 0.190 |
Why?
|
| Strongyloidiasis | 3 | 2006 | 27 | 0.190 |
Why?
|
| Immunomagnetic Separation | 1 | 2001 | 79 | 0.190 |
Why?
|
| DNA | 5 | 2022 | 7213 | 0.190 |
Why?
|
| Thrombosis | 1 | 2015 | 2942 | 0.190 |
Why?
|
| Palmitic Acid | 2 | 2020 | 149 | 0.190 |
Why?
|
| Cell Adhesion Molecules | 6 | 1996 | 1601 | 0.180 |
Why?
|
| Schistosomiasis mansoni | 2 | 2018 | 93 | 0.180 |
Why?
|
| Transforming Growth Factor alpha | 6 | 1998 | 135 | 0.180 |
Why?
|
| Cell-Free System | 2 | 2012 | 340 | 0.180 |
Why?
|
| Strongyloides stercoralis | 2 | 2006 | 23 | 0.180 |
Why?
|
| Proteins | 2 | 2014 | 6032 | 0.180 |
Why?
|
| Allergens | 1 | 2007 | 1432 | 0.170 |
Why?
|
| Primary Health Care | 1 | 2016 | 4687 | 0.170 |
Why?
|
| Platelet Membrane Glycoproteins | 3 | 2009 | 284 | 0.170 |
Why?
|
| Sulfatases | 3 | 1986 | 44 | 0.160 |
Why?
|
| Organ Specificity | 2 | 2017 | 1968 | 0.160 |
Why?
|
| Schistosoma | 1 | 2019 | 17 | 0.160 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2001 | 592 | 0.160 |
Why?
|
| Eosinophilic Granuloma | 1 | 2018 | 27 | 0.160 |
Why?
|
| Recombinant Proteins | 6 | 2018 | 6534 | 0.160 |
Why?
|
| Nematode Infections | 2 | 2000 | 19 | 0.160 |
Why?
|
| Mice, Transgenic | 6 | 2018 | 9542 | 0.160 |
Why?
|
| Protein Biosynthesis | 2 | 2014 | 2112 | 0.160 |
Why?
|
| Blood Proteins | 7 | 2009 | 1173 | 0.150 |
Why?
|
| Immunomodulation | 2 | 2014 | 549 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 8554 | 0.150 |
Why?
|
| Prostaglandins | 4 | 1992 | 398 | 0.150 |
Why?
|
| Aniline Compounds | 3 | 2013 | 1069 | 0.150 |
Why?
|
| Receptors, Interleukin-2 | 4 | 1996 | 562 | 0.140 |
Why?
|
| RNA | 4 | 2003 | 2725 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2009 | 1809 | 0.140 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 1991 | 540 | 0.140 |
Why?
|
| Cell Membrane | 3 | 2018 | 3687 | 0.140 |
Why?
|
| Disease Models, Animal | 8 | 2019 | 18255 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 5 | 2019 | 1964 | 0.140 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2019 | 347 | 0.140 |
Why?
|
| Bronchi | 5 | 2000 | 845 | 0.140 |
Why?
|
| Oncogene Proteins, Fusion | 4 | 2014 | 1609 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 489 | 0.140 |
Why?
|
| Elephantiasis, Filarial | 2 | 2001 | 31 | 0.140 |
Why?
|
| Protozoan Infections | 1 | 1996 | 38 | 0.130 |
Why?
|
| Plasma Cells | 1 | 2020 | 599 | 0.130 |
Why?
|
| Mouth Neoplasms | 3 | 1999 | 596 | 0.130 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 666 | 0.130 |
Why?
|
| Mice, Inbred C3H | 4 | 2007 | 915 | 0.130 |
Why?
|
| Protein Synthesis Inhibitors | 3 | 2005 | 189 | 0.130 |
Why?
|
| Certification | 1 | 1999 | 418 | 0.130 |
Why?
|
| Membrane Lipids | 2 | 1997 | 252 | 0.130 |
Why?
|
| Dirofilaria immitis | 2 | 1989 | 8 | 0.130 |
Why?
|
| Benzimidazoles | 1 | 2001 | 858 | 0.130 |
Why?
|
| Antiprotozoal Agents | 1 | 1996 | 94 | 0.130 |
Why?
|
| Qa-SNARE Proteins | 1 | 2015 | 52 | 0.130 |
Why?
|
| Hematologic Tests | 1 | 2016 | 239 | 0.130 |
Why?
|
| Leukotriene B4 | 4 | 2002 | 280 | 0.130 |
Why?
|
| Fetal Blood | 1 | 2002 | 1347 | 0.120 |
Why?
|
| Adoptive Transfer | 2 | 2008 | 819 | 0.120 |
Why?
|
| Dinoprostone | 2 | 2002 | 597 | 0.120 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2015 | 115 | 0.120 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 2018 | 303 | 0.120 |
Why?
|
| Receptors, IgG | 3 | 2012 | 559 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2002 | 1741 | 0.120 |
Why?
|
| Endothelial Growth Factors | 1 | 1997 | 673 | 0.120 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 4758 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2002 | 2273 | 0.120 |
Why?
|
| Peptide Hydrolases | 2 | 2015 | 624 | 0.120 |
Why?
|
| Interferon-gamma | 4 | 2008 | 3162 | 0.120 |
Why?
|
| Ivermectin | 2 | 1993 | 46 | 0.110 |
Why?
|
| Genes | 4 | 1994 | 1823 | 0.110 |
Why?
|
| Biological Products | 1 | 2023 | 914 | 0.110 |
Why?
|
| Immunoglobulin G | 4 | 2020 | 4544 | 0.110 |
Why?
|
| Dyspnea | 1 | 2002 | 1347 | 0.110 |
Why?
|
| Advisory Committees | 1 | 2018 | 787 | 0.110 |
Why?
|
| Receptors, Cell Surface | 3 | 2021 | 2822 | 0.110 |
Why?
|
| Stem Cell Factor | 1 | 2014 | 195 | 0.110 |
Why?
|
| Cell Adhesion | 4 | 1995 | 3088 | 0.110 |
Why?
|
| Macrophages | 6 | 2011 | 5767 | 0.110 |
Why?
|
| Parasitic Diseases | 2 | 1992 | 76 | 0.110 |
Why?
|
| Chemokine CCL21 | 1 | 2013 | 50 | 0.110 |
Why?
|
| Xanthenes | 1 | 2013 | 72 | 0.110 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 1993 | 64 | 0.110 |
Why?
|
| Decompression, Surgical | 1 | 2018 | 607 | 0.110 |
Why?
|
| Interleukin-13 | 3 | 2015 | 392 | 0.110 |
Why?
|
| 3T3 Cells | 1 | 1994 | 1085 | 0.110 |
Why?
|
| Phlebotomy | 1 | 2014 | 137 | 0.110 |
Why?
|
| RNA, Messenger | 14 | 2003 | 12794 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2002 | 1979 | 0.100 |
Why?
|
| Leukotriene D4 | 2 | 2002 | 33 | 0.100 |
Why?
|
| Rare Diseases | 1 | 2018 | 622 | 0.100 |
Why?
|
| Male | 61 | 2024 | 360846 | 0.100 |
Why?
|
| Blood Group Antigens | 1 | 1994 | 184 | 0.100 |
Why?
|
| Virulence Factors, Bordetella | 2 | 2002 | 154 | 0.100 |
Why?
|
| Pertussis Toxin | 2 | 2002 | 176 | 0.100 |
Why?
|
| Respiratory Tract Diseases | 2 | 2021 | 750 | 0.100 |
Why?
|
| Biological Transport, Active | 2 | 2009 | 328 | 0.100 |
Why?
|
| Glutathione Transferase | 2 | 1997 | 565 | 0.100 |
Why?
|
| Candida albicans | 1 | 2015 | 372 | 0.100 |
Why?
|
| Alternative Splicing | 1 | 1997 | 1093 | 0.100 |
Why?
|
| Cell Shape | 1 | 2013 | 371 | 0.100 |
Why?
|
| Mucins | 1 | 2015 | 568 | 0.100 |
Why?
|
| Interleukin-12 | 3 | 2003 | 584 | 0.100 |
Why?
|
| Meningitis | 1 | 1993 | 217 | 0.100 |
Why?
|
| Fever of Unknown Origin | 1 | 1992 | 94 | 0.100 |
Why?
|
| Gastrointestinal Diseases | 2 | 2012 | 1200 | 0.100 |
Why?
|
| Biological Factors | 2 | 2023 | 157 | 0.090 |
Why?
|
| Virus Diseases | 2 | 2021 | 718 | 0.090 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 1996 | 691 | 0.090 |
Why?
|
| Carbodiimides | 1 | 2011 | 10 | 0.090 |
Why?
|
| Esthetics | 1 | 2013 | 330 | 0.090 |
Why?
|
| Adjuvants, Immunologic | 2 | 2008 | 1036 | 0.090 |
Why?
|
| Osmium | 1 | 2011 | 18 | 0.090 |
Why?
|
| Angioedema | 3 | 2009 | 184 | 0.090 |
Why?
|
| Peroxidases | 3 | 1997 | 134 | 0.090 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2018 | 793 | 0.090 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2011 | 66 | 0.090 |
Why?
|
| Quinolines | 2 | 2010 | 765 | 0.090 |
Why?
|
| Protein Kinase C | 4 | 1997 | 1202 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2008 | 4352 | 0.090 |
Why?
|
| Diethylcarbamazine | 6 | 1990 | 23 | 0.090 |
Why?
|
| Sinusitis | 2 | 2015 | 991 | 0.090 |
Why?
|
| Benzamides | 2 | 2014 | 1371 | 0.090 |
Why?
|
| Azo Compounds | 1 | 2011 | 117 | 0.090 |
Why?
|
| Aldehyde Oxidase | 1 | 2010 | 4 | 0.090 |
Why?
|
| X Chromosome | 1 | 1994 | 816 | 0.090 |
Why?
|
| Leptin | 1 | 2018 | 1597 | 0.090 |
Why?
|
| Models, Neurological | 1 | 2018 | 1769 | 0.090 |
Why?
|
| Homeostasis | 2 | 2020 | 3323 | 0.090 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 1403 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 727 | 0.090 |
Why?
|
| Aspirin | 3 | 2001 | 3133 | 0.090 |
Why?
|
| Adult | 46 | 2024 | 221210 | 0.090 |
Why?
|
| Membranes, Artificial | 1 | 2011 | 366 | 0.080 |
Why?
|
| Macrophages, Alveolar | 1 | 1992 | 412 | 0.080 |
Why?
|
| Staphylococcus aureus | 3 | 2015 | 1457 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2006 | 1541 | 0.080 |
Why?
|
| Cartilage | 1 | 2013 | 806 | 0.080 |
Why?
|
| Magnetics | 1 | 2012 | 599 | 0.080 |
Why?
|
| Boron Compounds | 1 | 2011 | 182 | 0.080 |
Why?
|
| Interleukin-1 | 1 | 1993 | 1248 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 9 | 2012 | 9177 | 0.080 |
Why?
|
| Leukocyte Disorders | 1 | 2009 | 12 | 0.080 |
Why?
|
| Immunity, Cellular | 2 | 2010 | 1560 | 0.080 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 833 | 0.080 |
Why?
|
| Sulfides | 1 | 2010 | 169 | 0.080 |
Why?
|
| Chagas Disease | 1 | 2011 | 167 | 0.080 |
Why?
|
| Retroviridae Proteins | 1 | 1989 | 94 | 0.080 |
Why?
|
| Triiodobenzoic Acids | 1 | 2009 | 123 | 0.080 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2011 | 237 | 0.080 |
Why?
|
| Membrane Glycoproteins | 3 | 2003 | 3701 | 0.080 |
Why?
|
| Endothelium, Vascular | 3 | 2001 | 4431 | 0.080 |
Why?
|
| Lipoxygenase Inhibitors | 2 | 2001 | 93 | 0.080 |
Why?
|
| Communicable Diseases | 1 | 2017 | 875 | 0.080 |
Why?
|
| Platelet Aggregation | 1 | 1992 | 771 | 0.080 |
Why?
|
| Ovalbumin | 2 | 2007 | 677 | 0.080 |
Why?
|
| Oxazines | 1 | 2011 | 350 | 0.080 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 1117 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 1996 | 1252 | 0.080 |
Why?
|
| Acetates | 1 | 2010 | 321 | 0.080 |
Why?
|
| Arachidonate 15-Lipoxygenase | 2 | 2019 | 84 | 0.080 |
Why?
|
| Cyclopropanes | 1 | 2010 | 432 | 0.080 |
Why?
|
| Receptors, IgE | 1 | 2010 | 375 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2013 | 769 | 0.080 |
Why?
|
| Babesiosis | 1 | 1989 | 92 | 0.080 |
Why?
|
| Calcium | 3 | 2013 | 5722 | 0.080 |
Why?
|
| Ammonium Chloride | 1 | 2007 | 72 | 0.080 |
Why?
|
| Genistein | 2 | 1998 | 86 | 0.070 |
Why?
|
| Cell Differentiation | 5 | 2015 | 11530 | 0.070 |
Why?
|
| Giardia | 1 | 1987 | 7 | 0.070 |
Why?
|
| Fluorescent Dyes | 3 | 2000 | 1903 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2017 | 1590 | 0.070 |
Why?
|
| Female | 49 | 2024 | 392705 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2000 | 3617 | 0.070 |
Why?
|
| Receptors, Interleukin-4 | 2 | 2006 | 64 | 0.070 |
Why?
|
| Splenectomy | 1 | 1989 | 391 | 0.070 |
Why?
|
| Gastroenteritis | 1 | 2009 | 236 | 0.070 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 13642 | 0.070 |
Why?
|
| Rhinitis | 1 | 2015 | 747 | 0.070 |
Why?
|
| Transcription, Genetic | 4 | 1997 | 7593 | 0.070 |
Why?
|
| Cell Survival | 6 | 2015 | 5791 | 0.070 |
Why?
|
| Proteoglycans | 2 | 2009 | 803 | 0.070 |
Why?
|
| Respiratory System | 1 | 2011 | 563 | 0.070 |
Why?
|
| Antigens | 5 | 1982 | 1443 | 0.070 |
Why?
|
| Pleurisy | 4 | 2006 | 54 | 0.070 |
Why?
|
| Paracrine Communication | 2 | 2011 | 277 | 0.070 |
Why?
|
| Type C Phospholipases | 3 | 1996 | 287 | 0.070 |
Why?
|
| Glucocorticoids | 3 | 2017 | 2161 | 0.070 |
Why?
|
| Phosphatidylinositols | 4 | 1989 | 282 | 0.070 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1989 | 898 | 0.070 |
Why?
|
| Gene Expression Regulation | 5 | 2017 | 11904 | 0.070 |
Why?
|
| Mesoderm | 1 | 1989 | 674 | 0.070 |
Why?
|
| Antibodies | 3 | 2005 | 2418 | 0.070 |
Why?
|
| Liver Diseases | 2 | 2007 | 1297 | 0.070 |
Why?
|
| Skin Diseases, Parasitic | 1 | 2006 | 13 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 1486 | 0.070 |
Why?
|
| Immunoglobulins | 3 | 1997 | 852 | 0.070 |
Why?
|
| Adipocytes | 1 | 2013 | 1194 | 0.070 |
Why?
|
| Bromeliaceae | 1 | 2005 | 1 | 0.060 |
Why?
|
| Hypersensitivity, Immediate | 4 | 1984 | 347 | 0.060 |
Why?
|
| Piperazines | 2 | 2014 | 2523 | 0.060 |
Why?
|
| Pharmacogenetics | 1 | 2010 | 675 | 0.060 |
Why?
|
| Intestinal Obstruction | 1 | 2009 | 432 | 0.060 |
Why?
|
| Actins | 1 | 2013 | 2050 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2014 | 5672 | 0.060 |
Why?
|
| Interleukin-3 | 3 | 1998 | 425 | 0.060 |
Why?
|
| Uridine | 2 | 2003 | 141 | 0.060 |
Why?
|
| Cricetinae | 6 | 1999 | 2423 | 0.060 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2006 | 266 | 0.060 |
Why?
|
| Zoonoses | 2 | 1984 | 179 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2009 | 1881 | 0.060 |
Why?
|
| Pacific Islands | 5 | 1992 | 52 | 0.060 |
Why?
|
| Biomedical Research | 3 | 2021 | 3429 | 0.060 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 2018 | 105 | 0.060 |
Why?
|
| Antimony Sodium Gluconate | 1 | 2005 | 10 | 0.060 |
Why?
|
| Enzyme Inhibitors | 4 | 2009 | 3713 | 0.060 |
Why?
|
| Base Sequence | 10 | 1997 | 12441 | 0.060 |
Why?
|
| Avidin | 1 | 2005 | 43 | 0.060 |
Why?
|
| Purpura | 1 | 2006 | 117 | 0.060 |
Why?
|
| Biopsy | 6 | 2006 | 6766 | 0.060 |
Why?
|
| Recurrence | 3 | 2017 | 8466 | 0.060 |
Why?
|
| Eosinophil Peroxidase | 3 | 2015 | 21 | 0.060 |
Why?
|
| SEER Program | 1 | 2010 | 1450 | 0.060 |
Why?
|
| Viral Envelope Proteins | 1 | 1989 | 640 | 0.060 |
Why?
|
| Hypersensitivity, Delayed | 3 | 1980 | 490 | 0.060 |
Why?
|
| Trypanocidal Agents | 1 | 2005 | 41 | 0.060 |
Why?
|
| Syndrome | 8 | 2006 | 3267 | 0.060 |
Why?
|
| Histamine Release | 2 | 1995 | 134 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 2373 | 0.060 |
Why?
|
| Molecular Weight | 5 | 1989 | 2186 | 0.060 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2006 | 225 | 0.060 |
Why?
|
| Histamine | 5 | 1995 | 499 | 0.060 |
Why?
|
| Incidence | 3 | 2013 | 21355 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 945 | 0.060 |
Why?
|
| Middle Aged | 31 | 2024 | 220921 | 0.060 |
Why?
|
| Bone Marrow | 2 | 2014 | 2911 | 0.060 |
Why?
|
| Kinetics | 9 | 1992 | 6374 | 0.060 |
Why?
|
| Nose Diseases | 1 | 2005 | 79 | 0.060 |
Why?
|
| Diagnosis, Differential | 6 | 2009 | 12973 | 0.060 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2011 | 832 | 0.060 |
Why?
|
| Pyrimidines | 2 | 2014 | 3028 | 0.060 |
Why?
|
| Endothelium | 3 | 1993 | 765 | 0.060 |
Why?
|
| Receptors, Notch | 1 | 2009 | 744 | 0.060 |
Why?
|
| Esterification | 3 | 1989 | 39 | 0.060 |
Why?
|
| Lipoxygenase | 1 | 1983 | 72 | 0.060 |
Why?
|
| Anti-Allergic Agents | 1 | 2005 | 153 | 0.060 |
Why?
|
| Complement System Proteins | 3 | 1997 | 735 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1999 | 4024 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2009 | 710 | 0.060 |
Why?
|
| Cystic Fibrosis | 2 | 2004 | 1285 | 0.060 |
Why?
|
| Bombesin | 1 | 2003 | 35 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 1971 | 0.060 |
Why?
|
| Gels | 1 | 2005 | 420 | 0.060 |
Why?
|
| Cell Aggregation | 1 | 2024 | 239 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 1992 | 1391 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2016 | 3600 | 0.050 |
Why?
|
| Microbiological Techniques | 1 | 2004 | 97 | 0.050 |
Why?
|
| Molecular Sequence Data | 8 | 1999 | 17635 | 0.050 |
Why?
|
| Gene Expression | 2 | 2015 | 7581 | 0.050 |
Why?
|
| Escherichia coli | 2 | 2015 | 4217 | 0.050 |
Why?
|
| Mice, Knockout | 4 | 2015 | 14417 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 2 | 2002 | 597 | 0.050 |
Why?
|
| Viscosity | 1 | 2024 | 336 | 0.050 |
Why?
|
| DNA Primers | 3 | 1996 | 2820 | 0.050 |
Why?
|
| Eosinophil-Derived Neurotoxin | 1 | 2022 | 13 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 14665 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 2217 | 0.050 |
Why?
|
| Edetic Acid | 1 | 2003 | 276 | 0.050 |
Why?
|
| Nasal Obstruction | 1 | 2005 | 160 | 0.050 |
Why?
|
| Reoperation | 1 | 2013 | 4303 | 0.050 |
Why?
|
| In Situ Hybridization | 3 | 2003 | 1900 | 0.050 |
Why?
|
| Agammaglobulinemia | 1 | 1984 | 171 | 0.050 |
Why?
|
| Carbon Radioisotopes | 2 | 1998 | 561 | 0.050 |
Why?
|
| Lymphocyte Activation | 4 | 2001 | 5485 | 0.050 |
Why?
|
| Acetophenones | 1 | 2002 | 53 | 0.050 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 3462 | 0.050 |
Why?
|
| Leukotriene E4 | 1 | 2002 | 75 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2006 | 1880 | 0.050 |
Why?
|
| Myocardium | 1 | 2015 | 4725 | 0.050 |
Why?
|
| Japanese Encephalitis Vaccines | 1 | 2001 | 7 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2013 | 8321 | 0.050 |
Why?
|
| Electrons | 1 | 2003 | 265 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2013 | 8527 | 0.050 |
Why?
|
| Hepatitis A Vaccines | 1 | 2001 | 26 | 0.050 |
Why?
|
| Rabies Vaccines | 1 | 2001 | 27 | 0.050 |
Why?
|
| Tritium | 3 | 1992 | 708 | 0.050 |
Why?
|
| Ligands | 1 | 2009 | 3272 | 0.050 |
Why?
|
| Indomethacin | 2 | 2001 | 325 | 0.050 |
Why?
|
| Chemokine CCL24 | 1 | 2001 | 8 | 0.050 |
Why?
|
| Antigens, Helminth | 1 | 2001 | 68 | 0.050 |
Why?
|
| Sputum | 1 | 2004 | 506 | 0.050 |
Why?
|
| Propionates | 1 | 2002 | 183 | 0.050 |
Why?
|
| Fever | 1 | 1989 | 1618 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2005 | 497 | 0.050 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 1 | 2001 | 39 | 0.050 |
Why?
|
| HIV | 1 | 1989 | 1582 | 0.050 |
Why?
|
| Yellow Fever Vaccine | 1 | 2001 | 37 | 0.050 |
Why?
|
| Autoradiography | 3 | 2000 | 728 | 0.050 |
Why?
|
| Reference Values | 5 | 1998 | 4920 | 0.050 |
Why?
|
| Antibodies, Helminth | 1 | 2001 | 57 | 0.050 |
Why?
|
| Drug Therapy, Combination | 4 | 2017 | 6312 | 0.050 |
Why?
|
| Guinea Pigs | 4 | 1996 | 1310 | 0.050 |
Why?
|
| Mesocricetus | 2 | 1999 | 252 | 0.050 |
Why?
|
| United States | 9 | 2018 | 72340 | 0.050 |
Why?
|
| Macromolecular Substances | 2 | 2000 | 1434 | 0.050 |
Why?
|
| Headache | 1 | 1989 | 1256 | 0.050 |
Why?
|
| Gerbillinae | 2 | 1992 | 87 | 0.050 |
Why?
|
| Nose | 1 | 2005 | 521 | 0.050 |
Why?
|
| Africa, Western | 1 | 2001 | 159 | 0.050 |
Why?
|
| Isoenzymes | 2 | 2002 | 1687 | 0.050 |
Why?
|
| Pulmonary Atelectasis | 1 | 2002 | 143 | 0.050 |
Why?
|
| Cytosol | 2 | 1998 | 888 | 0.050 |
Why?
|
| Cestode Infections | 1 | 2000 | 6 | 0.050 |
Why?
|
| Trematode Infections | 1 | 2000 | 3 | 0.050 |
Why?
|
| Interleukin-2 | 3 | 1992 | 1889 | 0.050 |
Why?
|
| Hepatitis C | 1 | 2011 | 1584 | 0.050 |
Why?
|
| Aged | 20 | 2024 | 169310 | 0.050 |
Why?
|
| Isoxazoles | 1 | 2002 | 232 | 0.040 |
Why?
|
| Nasal Mucosa | 1 | 2024 | 416 | 0.040 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2002 | 321 | 0.040 |
Why?
|
| Biotinylation | 1 | 2000 | 184 | 0.040 |
Why?
|
| Fibroblasts | 2 | 1995 | 4142 | 0.040 |
Why?
|
| Protein Binding | 3 | 2006 | 9353 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 20100 | 0.040 |
Why?
|
| Lectins | 2 | 1993 | 491 | 0.040 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2001 | 306 | 0.040 |
Why?
|
| Ribosomes | 1 | 2003 | 501 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2015 | 12130 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2013 | 5971 | 0.040 |
Why?
|
| Rabbits | 3 | 2002 | 4772 | 0.040 |
Why?
|
| E-Selectin | 2 | 1992 | 576 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2001 | 229 | 0.040 |
Why?
|
| Phospholipids | 3 | 1988 | 786 | 0.040 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2003 | 326 | 0.040 |
Why?
|
| Lung Diseases | 2 | 2007 | 1909 | 0.040 |
Why?
|
| Bacterial Proteins | 3 | 2003 | 3847 | 0.040 |
Why?
|
| Hydantoins | 1 | 2018 | 12 | 0.040 |
Why?
|
| Fatty Acids | 1 | 1987 | 1808 | 0.040 |
Why?
|
| Health Services for the Aged | 1 | 2001 | 259 | 0.040 |
Why?
|
| Palmitic Acids | 2 | 1989 | 53 | 0.040 |
Why?
|
| High Mobility Group Proteins | 1 | 1999 | 177 | 0.040 |
Why?
|
| Adolescent | 17 | 2013 | 88326 | 0.040 |
Why?
|
| Quinones | 1 | 1998 | 78 | 0.040 |
Why?
|
| Schistosomiasis | 1 | 1979 | 65 | 0.040 |
Why?
|
| Skin Tests | 1 | 2000 | 637 | 0.040 |
Why?
|
| Rifabutin | 1 | 1998 | 59 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1998 | 2425 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2007 | 4125 | 0.040 |
Why?
|
| Amine Oxidase (Copper-Containing) | 2 | 1995 | 41 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 1997 | 6075 | 0.040 |
Why?
|
| Education | 1 | 2001 | 537 | 0.040 |
Why?
|
| Forecasting | 1 | 2007 | 2928 | 0.040 |
Why?
|
| Diglycerides | 2 | 1991 | 177 | 0.040 |
Why?
|
| Dimerization | 1 | 2000 | 891 | 0.040 |
Why?
|
| Pericytes | 1 | 2001 | 293 | 0.040 |
Why?
|
| Double-Blind Method | 4 | 2018 | 12341 | 0.040 |
Why?
|
| HIV-1 | 1 | 1995 | 6863 | 0.040 |
Why?
|
| Benzoquinones | 1 | 1998 | 198 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2001 | 696 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 9610 | 0.040 |
Why?
|
| Phospholipases A2 | 1 | 1998 | 197 | 0.040 |
Why?
|
| Feces | 2 | 2001 | 1497 | 0.040 |
Why?
|
| Benzophenanthridines | 1 | 1997 | 27 | 0.040 |
Why?
|
| Blepharitis | 2 | 1995 | 35 | 0.040 |
Why?
|
| Phenanthridines | 1 | 1997 | 51 | 0.040 |
Why?
|
| Prednisolone | 1 | 2018 | 326 | 0.040 |
Why?
|
| Phosphotyrosine | 1 | 1998 | 456 | 0.040 |
Why?
|
| Brugia malayi | 1 | 1997 | 5 | 0.040 |
Why?
|
| Cloning, Molecular | 4 | 1997 | 4174 | 0.040 |
Why?
|
| Lymphedema | 1 | 1984 | 525 | 0.040 |
Why?
|
| Adenosine Diphosphate | 2 | 2015 | 422 | 0.040 |
Why?
|
| Complement C5 | 2 | 1995 | 103 | 0.040 |
Why?
|
| Pericardium | 1 | 2002 | 675 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 427 | 0.040 |
Why?
|
| Cromolyn Sodium | 1 | 1997 | 78 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2000 | 535 | 0.040 |
Why?
|
| Neural Conduction | 1 | 2018 | 441 | 0.040 |
Why?
|
| Wound Healing | 3 | 1997 | 2805 | 0.040 |
Why?
|
| Time Factors | 15 | 2005 | 39969 | 0.030 |
Why?
|
| Dogs | 2 | 2010 | 3839 | 0.030 |
Why?
|
| Lactams, Macrocyclic | 1 | 1998 | 318 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2007 | 1667 | 0.030 |
Why?
|
| Mucoproteins | 1 | 1996 | 49 | 0.030 |
Why?
|
| Esters | 2 | 1988 | 211 | 0.030 |
Why?
|
| Isoflavones | 1 | 1997 | 136 | 0.030 |
Why?
|
| RNA, Small Nuclear | 2 | 1987 | 75 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 1010 | 0.030 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1996 | 141 | 0.030 |
Why?
|
| Integrin alpha4beta1 | 1 | 1996 | 119 | 0.030 |
Why?
|
| Tetrazoles | 1 | 2002 | 909 | 0.030 |
Why?
|
| Alkaloids | 1 | 1997 | 192 | 0.030 |
Why?
|
| Structure-Activity Relationship | 4 | 2012 | 3076 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2017 | 413 | 0.030 |
Why?
|
| Genes, gag | 1 | 1995 | 55 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2002 | 909 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2018 | 64685 | 0.030 |
Why?
|
| Blotting, Northern | 3 | 1993 | 1545 | 0.030 |
Why?
|
| Amino Acid Sequence | 5 | 1999 | 13446 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1997 | 748 | 0.030 |
Why?
|
| Androstadienes | 1 | 1997 | 348 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2017 | 681 | 0.030 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2015 | 49 | 0.030 |
Why?
|
| Gold | 2 | 2000 | 482 | 0.030 |
Why?
|
| Phagosomes | 1 | 2017 | 199 | 0.030 |
Why?
|
| Growth | 1 | 1997 | 365 | 0.030 |
Why?
|
| HIV Core Protein p24 | 1 | 1995 | 245 | 0.030 |
Why?
|
| Oral Ulcer | 1 | 1996 | 96 | 0.030 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1995 | 74 | 0.030 |
Why?
|
| Affinity Labels | 1 | 1995 | 107 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 1997 | 300 | 0.030 |
Why?
|
| Liver | 3 | 2018 | 7528 | 0.030 |
Why?
|
| Respiratory Burst | 1 | 1995 | 110 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2011 | 3407 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2002 | 2206 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2008 | 3080 | 0.030 |
Why?
|
| Intestinal Mucosa | 3 | 1995 | 3032 | 0.030 |
Why?
|
| Albuterol | 1 | 1995 | 213 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2000 | 983 | 0.030 |
Why?
|
| Young Adult | 4 | 2018 | 59260 | 0.030 |
Why?
|
| Receptors, Complement | 3 | 1995 | 253 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2001 | 1492 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 1997 | 1991 | 0.030 |
Why?
|
| Placebos | 1 | 2018 | 1667 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2007 | 2781 | 0.030 |
Why?
|
| Chlorides | 2 | 1994 | 665 | 0.030 |
Why?
|
| Cell Nucleus | 3 | 2003 | 2910 | 0.030 |
Why?
|
| Rats | 7 | 2010 | 23741 | 0.030 |
Why?
|
| GTP-Binding Proteins | 2 | 1996 | 951 | 0.030 |
Why?
|
| Superoxides | 2 | 1995 | 387 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 1996 | 728 | 0.030 |
Why?
|
| Crossing Over, Genetic | 1 | 1994 | 92 | 0.030 |
Why?
|
| Canada | 1 | 1999 | 2122 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 1995 | 345 | 0.030 |
Why?
|
| Thiabendazole | 1 | 1993 | 2 | 0.030 |
Why?
|
| Binding Sites | 3 | 1997 | 6056 | 0.030 |
Why?
|
| Peer Review, Research | 1 | 2017 | 340 | 0.030 |
Why?
|
| Prognosis | 2 | 2013 | 29629 | 0.030 |
Why?
|
| Trachea | 1 | 2000 | 1089 | 0.030 |
Why?
|
| Skin | 5 | 2006 | 4484 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1787 | 0.030 |
Why?
|
| Bone Marrow Cells | 3 | 2015 | 2417 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2018 | 80647 | 0.030 |
Why?
|
| Albendazole | 1 | 1993 | 50 | 0.030 |
Why?
|
| Monokines | 1 | 1993 | 71 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1997 | 2748 | 0.030 |
Why?
|
| Endoribonucleases | 1 | 2015 | 228 | 0.030 |
Why?
|
| Wounds, Penetrating | 1 | 1996 | 313 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 2139 | 0.030 |
Why?
|
| Mouth Mucosa | 1 | 1996 | 432 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 39106 | 0.030 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2012 | 9 | 0.030 |
Why?
|
| Epithelium | 5 | 1997 | 1603 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1996 | 702 | 0.030 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1994 | 207 | 0.030 |
Why?
|
| Databases as Topic | 2 | 2005 | 473 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2001 | 1664 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2017 | 697 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2001 | 2932 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 4 | 2015 | 22174 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2024 | 9319 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 1998 | 6131 | 0.030 |
Why?
|
| Models, Biological | 2 | 2007 | 9469 | 0.030 |
Why?
|
| Nasal Polyps | 2 | 1996 | 395 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1996 | 2264 | 0.030 |
Why?
|
| Adenosine Monophosphate | 1 | 1993 | 231 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 1994 | 1126 | 0.020 |
Why?
|
| Methysergide | 1 | 1991 | 28 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1991 | 1302 | 0.020 |
Why?
|
| Bronchodilator Agents | 1 | 1995 | 512 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2002 | 2009 | 0.020 |
Why?
|
| Asia, Southeastern | 1 | 1992 | 114 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1993 | 189 | 0.020 |
Why?
|
| Eyelids | 1 | 1994 | 278 | 0.020 |
Why?
|
| Bronchial Hyperreactivity | 1 | 1993 | 302 | 0.020 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 1992 | 224 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 23996 | 0.020 |
Why?
|
| Erythrocyte Membrane | 2 | 1984 | 439 | 0.020 |
Why?
|
| HIV Infections | 2 | 1995 | 17354 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2011 | 201 | 0.020 |
Why?
|
| Quality of Life | 1 | 2013 | 13367 | 0.020 |
Why?
|
| Fibronectins | 1 | 1995 | 723 | 0.020 |
Why?
|
| Remission Induction | 1 | 2017 | 2397 | 0.020 |
Why?
|
| Necrosis | 1 | 1995 | 1611 | 0.020 |
Why?
|
| Saliva | 1 | 1996 | 828 | 0.020 |
Why?
|
| Plant Lectins | 1 | 1991 | 103 | 0.020 |
Why?
|
| Arthritis | 1 | 1996 | 680 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2012 | 357 | 0.020 |
Why?
|
| Risk Factors | 2 | 2016 | 74213 | 0.020 |
Why?
|
| Lipocalins | 1 | 2011 | 161 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 1991 | 426 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 1992 | 395 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2012 | 257 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1990 | 75 | 0.020 |
Why?
|
| Radiography | 1 | 2002 | 6965 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 1990 | 213 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15633 | 0.020 |
Why?
|
| Thromboxane B2 | 1 | 1990 | 143 | 0.020 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 1991 | 138 | 0.020 |
Why?
|
| ROC Curve | 1 | 2018 | 3578 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 1994 | 815 | 0.020 |
Why?
|
| Rats, Inbred BB | 1 | 2010 | 29 | 0.020 |
Why?
|
| Chromatin | 1 | 2022 | 2961 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 41495 | 0.020 |
Why?
|
| Iodopyracet | 1 | 1969 | 2 | 0.020 |
Why?
|
| Chemokine CCL17 | 1 | 2009 | 26 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2002 | 2330 | 0.020 |
Why?
|
| Pleura | 1 | 1991 | 245 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1991 | 817 | 0.020 |
Why?
|
| Catalysis | 1 | 2011 | 774 | 0.020 |
Why?
|
| Publishing | 1 | 2017 | 833 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 1993 | 909 | 0.020 |
Why?
|
| Piperidines | 1 | 2018 | 1656 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2017 | 815 | 0.020 |
Why?
|
| Leukapheresis | 1 | 1990 | 134 | 0.020 |
Why?
|
| Linoleic Acids | 1 | 1989 | 39 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1997 | 1948 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1994 | 2180 | 0.020 |
Why?
|
| Pain | 1 | 2005 | 5073 | 0.020 |
Why?
|
| Keratins | 1 | 1991 | 498 | 0.020 |
Why?
|
| Oleic Acids | 1 | 1989 | 74 | 0.020 |
Why?
|
| Lipoxins | 1 | 1992 | 419 | 0.020 |
Why?
|
| Oleic Acid | 1 | 1989 | 92 | 0.020 |
Why?
|
| Quinine | 1 | 1989 | 51 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1998 | 2448 | 0.020 |
Why?
|
| Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins | 1 | 2009 | 11 | 0.020 |
Why?
|
| Babesia | 1 | 1989 | 29 | 0.020 |
Why?
|
| Ticks | 1 | 1989 | 70 | 0.020 |
Why?
|
| Colony-Stimulating Factors | 1 | 1989 | 218 | 0.020 |
Why?
|
| Haplorhini | 1 | 2010 | 525 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1994 | 1519 | 0.020 |
Why?
|
| Plasmapheresis | 1 | 1990 | 206 | 0.020 |
Why?
|
| Collodion | 1 | 1988 | 34 | 0.020 |
Why?
|
| Complement C8 | 1 | 1988 | 5 | 0.020 |
Why?
|
| Carbohydrates | 1 | 1991 | 390 | 0.020 |
Why?
|
| Clindamycin | 1 | 1989 | 139 | 0.020 |
Why?
|
| Half-Life | 1 | 2010 | 651 | 0.020 |
Why?
|
| Hematopoiesis | 2 | 2011 | 2050 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1999 | 2568 | 0.020 |
Why?
|
| Tryptases | 1 | 2009 | 176 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1995 | 2202 | 0.020 |
Why?
|
| Endocytosis | 3 | 1990 | 957 | 0.020 |
Why?
|
| Child | 14 | 2009 | 80158 | 0.020 |
Why?
|
| Gingiva | 1 | 1991 | 410 | 0.020 |
Why?
|
| Hydroxyurea | 1 | 2009 | 284 | 0.020 |
Why?
|
| Extracellular Matrix | 2 | 1993 | 1726 | 0.020 |
Why?
|
| Linoleic Acid | 1 | 1989 | 158 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3878 | 0.020 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1988 | 71 | 0.020 |
Why?
|
| Calcimycin | 2 | 1988 | 213 | 0.020 |
Why?
|
| Urticaria | 1 | 2009 | 150 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4576 | 0.020 |
Why?
|
| Exons | 1 | 1994 | 2391 | 0.020 |
Why?
|
| Filtration | 1 | 1988 | 228 | 0.020 |
Why?
|
| Hemolysis | 2 | 1995 | 415 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 1969 | 449 | 0.020 |
Why?
|
| Crohn Disease | 2 | 1995 | 2279 | 0.020 |
Why?
|
| Jejunum | 1 | 2009 | 472 | 0.020 |
Why?
|
| Societies, Medical | 1 | 1999 | 3905 | 0.020 |
Why?
|
| Pyrimidinones | 1 | 2010 | 385 | 0.020 |
Why?
|
| Growth Substances | 1 | 1989 | 768 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 1762 | 0.020 |
Why?
|
| RNA Polymerase III | 1 | 1987 | 58 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1988 | 646 | 0.020 |
Why?
|
| Airway Resistance | 2 | 1993 | 406 | 0.020 |
Why?
|
| Collagen | 1 | 2015 | 2638 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2009 | 778 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1988 | 462 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1988 | 532 | 0.020 |
Why?
|
| Cross-Linking Reagents | 2 | 2003 | 687 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 6815 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 15502 | 0.020 |
Why?
|
| Protein Conformation | 2 | 1986 | 3968 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1987 | 373 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 1997 | 3492 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2010 | 1574 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4281 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1994 | 4615 | 0.020 |
Why?
|
| DNA Damage | 1 | 1995 | 2449 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 2414 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 1768 | 0.020 |
Why?
|
| Prostaglandins B | 1 | 1985 | 5 | 0.020 |
Why?
|
| p-Chloromercuribenzoic Acid | 1 | 1984 | 1 | 0.020 |
Why?
|
| Chloromercuribenzoates | 1 | 1984 | 5 | 0.020 |
Why?
|
| Prostaglandins A | 1 | 1985 | 13 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2009 | 921 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2009 | 774 | 0.020 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 1987 | 367 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1997 | 3397 | 0.020 |
Why?
|
| Malta | 1 | 1984 | 6 | 0.010 |
Why?
|
| Libya | 1 | 1984 | 9 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2012 | 1530 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1991 | 1989 | 0.010 |
Why?
|
| Plant Leaves | 1 | 2005 | 150 | 0.010 |
Why?
|
| Oklahoma | 1 | 1984 | 36 | 0.010 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 1 | 1984 | 45 | 0.010 |
Why?
|
| Hypothyroidism | 1 | 2009 | 668 | 0.010 |
Why?
|
| Interleukins | 1 | 1989 | 782 | 0.010 |
Why?
|
| Arachidonate Lipoxygenases | 1 | 1983 | 16 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1985 | 405 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 1069 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 1997 | 4415 | 0.010 |
Why?
|
| World Health Organization | 1 | 2010 | 1322 | 0.010 |
Why?
|
| Myoglobin | 1 | 1984 | 159 | 0.010 |
Why?
|
| Lysophosphatidylcholines | 1 | 1984 | 77 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2012 | 3733 | 0.010 |
Why?
|
| Logistic Models | 1 | 2018 | 13255 | 0.010 |
Why?
|
| Benzopyrenes | 1 | 1983 | 5 | 0.010 |
Why?
|
| Administration, Inhalation | 2 | 1997 | 1157 | 0.010 |
Why?
|
| Peptides | 2 | 2012 | 4358 | 0.010 |
Why?
|
| Complement C3 | 2 | 1982 | 435 | 0.010 |
Why?
|
| Globins | 1 | 1984 | 404 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1983 | 173 | 0.010 |
Why?
|
| Apoptosis | 2 | 1996 | 9490 | 0.010 |
Why?
|
| HLA Antigens | 2 | 1994 | 1328 | 0.010 |
Why?
|
| Complement Activating Enzymes | 1 | 1982 | 22 | 0.010 |
Why?
|
| Complement C3-C5 Convertases | 1 | 1982 | 30 | 0.010 |
Why?
|
| Software | 1 | 2017 | 4434 | 0.010 |
Why?
|
| Child, Preschool | 8 | 2001 | 42232 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2000 | 7406 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15266 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2002 | 436 | 0.010 |
Why?
|
| Culture Media | 1 | 2004 | 897 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1997 | 6567 | 0.010 |
Why?
|
| Complement Activation | 1 | 1984 | 445 | 0.010 |
Why?
|
| Neurosecretory Systems | 1 | 2003 | 223 | 0.010 |
Why?
|
| Organoids | 1 | 1988 | 746 | 0.010 |
Why?
|
| Health Maintenance Organizations | 1 | 2004 | 659 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2008 | 2643 | 0.010 |
Why?
|
| Immune Sera | 1 | 1982 | 606 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1651 | 0.010 |
Why?
|
| Papio | 1 | 2003 | 669 | 0.010 |
Why?
|
| Immune System Diseases | 1 | 1984 | 256 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 58984 | 0.010 |
Why?
|
| Splenomegaly | 1 | 2002 | 189 | 0.010 |
Why?
|
| R-SNARE Proteins | 1 | 2001 | 75 | 0.010 |
Why?
|
| Parasitemia | 1 | 2001 | 165 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2006 | 1835 | 0.010 |
Why?
|
| Shock, Septic | 2 | 2002 | 768 | 0.010 |
Why?
|
| Crystallography | 1 | 1980 | 116 | 0.010 |
Why?
|
| Intradermal Tests | 1 | 1980 | 42 | 0.010 |
Why?
|
| Venules | 1 | 2001 | 161 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1992 | 2775 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1983 | 412 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1987 | 1363 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 1989 | 1407 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1980 | 340 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 2006 | 858 | 0.010 |
Why?
|
| Occupations | 1 | 1982 | 515 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 9001 | 0.010 |
Why?
|
| Heat-Shock Response | 1 | 2001 | 179 | 0.010 |
Why?
|
| Cephalosporins | 1 | 2000 | 198 | 0.010 |
Why?
|
| Mesothelioma | 1 | 1986 | 807 | 0.010 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2002 | 208 | 0.010 |
Why?
|
| Cattle | 2 | 2001 | 3849 | 0.010 |
Why?
|
| Niridazole | 1 | 1979 | 1 | 0.010 |
Why?
|
| Hypertension, Portal | 1 | 2002 | 226 | 0.010 |
Why?
|
| Neoplasms | 2 | 2006 | 22173 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2004 | 702 | 0.010 |
Why?
|
| Peritoneal Neoplasms | 1 | 1986 | 711 | 0.010 |
Why?
|
| Glucuronidase | 1 | 1981 | 202 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 9420 | 0.010 |
Why?
|
| Streptodornase and Streptokinase | 1 | 1978 | 8 | 0.010 |
Why?
|
| Spleen | 1 | 2005 | 2295 | 0.010 |
Why?
|
| Puromycin | 1 | 1978 | 42 | 0.010 |
Why?
|
| Tuberculin | 1 | 1978 | 64 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1996 | 10194 | 0.010 |
Why?
|
| SOX9 Transcription Factor | 1 | 1999 | 145 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2872 | 0.010 |
Why?
|
| Amino Acids | 1 | 1984 | 1718 | 0.010 |
Why?
|
| Epitopes | 2 | 1982 | 2503 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1990 | 2539 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2001 | 657 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1978 | 212 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2001 | 562 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 1998 | 194 | 0.010 |
Why?
|
| Respiratory Mechanics | 1 | 2002 | 699 | 0.010 |
Why?
|
| Triglycerides | 1 | 1985 | 2461 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2002 | 12149 | 0.010 |
Why?
|
| Penicillins | 1 | 2000 | 402 | 0.010 |
Why?
|
| Destrin | 1 | 1997 | 10 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1998 | 279 | 0.010 |
Why?
|
| Infant | 4 | 2001 | 36193 | 0.010 |
Why?
|
| COS Cells | 1 | 1999 | 1130 | 0.010 |
Why?
|
| Glia Maturation Factor | 1 | 1997 | 13 | 0.010 |
Why?
|
| Lysosomes | 1 | 1983 | 924 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2007 | 22176 | 0.010 |
Why?
|
| Actin Depolymerizing Factors | 1 | 1997 | 42 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 1996 | 167 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1997 | 413 | 0.010 |
Why?
|
| Optics and Photonics | 1 | 1978 | 306 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1980 | 1351 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 8002 | 0.010 |
Why?
|
| Periodicity | 1 | 1978 | 348 | 0.010 |
Why?
|
| Tetanus Toxoid | 1 | 1996 | 189 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1978 | 1157 | 0.010 |
Why?
|
| Complement C7 | 1 | 1995 | 15 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2003 | 2919 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1988 | 4937 | 0.010 |
Why?
|
| Larva | 1 | 1997 | 508 | 0.010 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1995 | 221 | 0.010 |
Why?
|
| Enterotoxins | 1 | 1996 | 366 | 0.010 |
Why?
|
| Receptors, Mitogen | 1 | 1994 | 61 | 0.010 |
Why?
|
| Mutation | 1 | 1999 | 30053 | 0.010 |
Why?
|
| Cell Line | 4 | 1993 | 15601 | 0.010 |
Why?
|
| Cell Division | 2 | 1996 | 4465 | 0.010 |
Why?
|
| Trypsin | 1 | 1995 | 495 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 3763 | 0.010 |
Why?
|
| Salivary Glands | 1 | 1996 | 229 | 0.010 |
Why?
|
| Intestinal Absorption | 1 | 1995 | 400 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1979 | 1395 | 0.010 |
Why?
|
| Tissue Fixation | 1 | 1995 | 241 | 0.010 |
Why?
|
| Rhodamines | 1 | 1994 | 178 | 0.010 |
Why?
|
| Theophylline | 1 | 1993 | 131 | 0.010 |
Why?
|
| Chemokine CCL4 | 1 | 1993 | 126 | 0.010 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 1993 | 121 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1999 | 1756 | 0.010 |
Why?
|
| Bronchial Provocation Tests | 1 | 1993 | 216 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 1993 | 220 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1982 | 2413 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1990 | 6345 | 0.010 |
Why?
|
| Polylysine | 1 | 1993 | 131 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 1993 | 135 | 0.010 |
Why?
|
| Cations | 1 | 1993 | 238 | 0.010 |
Why?
|
| Epithelial Cells | 2 | 1997 | 3677 | 0.010 |
Why?
|
| Xenopus laevis | 2 | 1987 | 963 | 0.010 |
Why?
|
| Lung Transplantation | 1 | 2002 | 1310 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 1990 | 5368 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1993 | 777 | 0.010 |
Why?
|
| Endocarditis, Subacute Bacterial | 1 | 1991 | 8 | 0.010 |
Why?
|
| Drug Hypersensitivity | 1 | 2000 | 917 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2003 | 26202 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 1997 | 1134 | 0.010 |
Why?
|
| Fluorescence | 1 | 1994 | 756 | 0.010 |
Why?
|
| Pregnancy | 1 | 1993 | 29890 | 0.010 |
Why?
|
| Mammals | 1 | 1997 | 1132 | 0.010 |
Why?
|
| Cell Polarity | 1 | 1994 | 636 | 0.010 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 1990 | 58 | 0.010 |
Why?
|
| Cluster Headache | 1 | 1991 | 54 | 0.010 |
Why?
|
| Body Height | 1 | 1997 | 1570 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1992 | 1141 | 0.010 |
Why?
|
| Galectin 3 | 1 | 1993 | 240 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2004 | 8633 | 0.010 |
Why?
|
| Complement C4 | 2 | 1982 | 217 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 416 | 0.010 |
Why?
|
| Phenolphthaleins | 1 | 1969 | 5 | 0.010 |
Why?
|
| Aminohippuric Acids | 1 | 1969 | 8 | 0.010 |
Why?
|
| Iodine Isotopes | 1 | 1969 | 79 | 0.010 |
Why?
|
| Propranolol | 1 | 1991 | 489 | 0.010 |
Why?
|
| Aerosols | 2 | 1983 | 635 | 0.010 |
Why?
|
| Serotonin | 1 | 1994 | 1041 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1997 | 1819 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1997 | 4853 | 0.010 |
Why?
|
| Phylogeny | 1 | 1997 | 2811 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1999 | 5439 | 0.010 |
Why?
|
| Vaccination | 1 | 2001 | 3384 | 0.010 |
Why?
|
| Oxygen | 1 | 2001 | 4227 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 13510 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1990 | 698 | 0.010 |
Why?
|
| Plasma Exchange | 1 | 1990 | 159 | 0.000 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 1989 | 186 | 0.000 |
Why?
|
| Glucose | 1 | 2001 | 4347 | 0.000 |
Why?
|
| Complement C5a | 1 | 1989 | 100 | 0.000 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 1989 | 87 | 0.000 |
Why?
|
| Peptide Mapping | 1 | 1989 | 262 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2009 | 20568 | 0.000 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1996 | 1802 | 0.000 |
Why?
|
| Sepsis | 1 | 2002 | 2585 | 0.000 |
Why?
|
| ABO Blood-Group System | 1 | 1991 | 380 | 0.000 |
Why?
|
| Trans-Activators | 1 | 1998 | 2856 | 0.000 |
Why?
|
| Blood Volume | 1 | 1990 | 547 | 0.000 |
Why?
|
| Heart Transplantation | 1 | 2002 | 3233 | 0.000 |
Why?
|
| X-Ray Diffraction | 1 | 1988 | 421 | 0.000 |
Why?
|
| DNA Polymerase I | 1 | 1987 | 43 | 0.000 |
Why?
|
| RNA, Neoplasm | 1 | 1990 | 750 | 0.000 |
Why?
|
| Sex Factors | 1 | 2001 | 10554 | 0.000 |
Why?
|
| Acute Disease | 1 | 1978 | 7237 | 0.000 |
Why?
|
| 5,8,11,14-Eicosatetraynoic Acid | 1 | 1986 | 9 | 0.000 |
Why?
|
| Receptors, Histamine H2 | 1 | 1986 | 18 | 0.000 |
Why?
|
| Peroxidase | 1 | 1990 | 609 | 0.000 |
Why?
|
| Cycloheximide | 1 | 1986 | 343 | 0.000 |
Why?
|
| Fishes | 1 | 1969 | 603 | 0.000 |
Why?
|
| Melanoma | 1 | 1985 | 5709 | 0.000 |
Why?
|
| Carrier State | 1 | 1989 | 523 | 0.000 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 4740 | 0.000 |
Why?
|
| Physical Examination | 1 | 1992 | 1255 | 0.000 |
Why?
|
| Intestines | 1 | 1995 | 1910 | 0.000 |
Why?
|
| Virulence | 1 | 1989 | 1303 | 0.000 |
Why?
|
| Cold Temperature | 1 | 1989 | 785 | 0.000 |
Why?
|
| Perfusion | 1 | 1969 | 1373 | 0.000 |
Why?
|
| Age Factors | 1 | 2001 | 18399 | 0.000 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1986 | 1058 | 0.000 |
Why?
|
| Prevalence | 1 | 2001 | 15733 | 0.000 |
Why?
|
| Cell Count | 1 | 1988 | 1835 | 0.000 |
Why?
|
| Hybrid Cells | 1 | 1984 | 422 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1984 | 550 | 0.000 |
Why?
|
| Counseling | 1 | 1992 | 1547 | 0.000 |
Why?
|
| Complement Membrane Attack Complex | 1 | 1984 | 105 | 0.000 |
Why?
|
| Algorithms | 1 | 2004 | 14033 | 0.000 |
Why?
|
| Poly G | 1 | 1983 | 7 | 0.000 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1984 | 364 | 0.000 |
Why?
|
| Guanosine | 1 | 1983 | 48 | 0.000 |
Why?
|
| Antigens, Neoplasm | 1 | 1991 | 1993 | 0.000 |
Why?
|
| Circular Dichroism | 1 | 1983 | 344 | 0.000 |
Why?
|
| Complement C2 | 1 | 1982 | 46 | 0.000 |
Why?
|
| Prostaglandins F | 1 | 1982 | 80 | 0.000 |
Why?
|
| Multigene Family | 1 | 1986 | 1076 | 0.000 |
Why?
|
| Complement C3b | 1 | 1982 | 97 | 0.000 |
Why?
|
| Chemistry | 1 | 1982 | 347 | 0.000 |
Why?
|
| Oocytes | 1 | 1987 | 1166 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1982 | 507 | 0.000 |
Why?
|
| Phenotype | 2 | 1991 | 16592 | 0.000 |
Why?
|
| Stereoisomerism | 1 | 1983 | 614 | 0.000 |
Why?
|
| Plasmids | 1 | 1987 | 2269 | 0.000 |
Why?
|
| Polynesia | 1 | 1981 | 14 | 0.000 |
Why?
|
| Space-Time Clustering | 1 | 1981 | 45 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 8181 | 0.000 |
Why?
|
| Sheep | 1 | 1984 | 1440 | 0.000 |
Why?
|
| HeLa Cells | 1 | 1987 | 3094 | 0.000 |
Why?
|
| Vital Capacity | 1 | 1983 | 971 | 0.000 |
Why?
|
| Hydroxy Acids | 1 | 1980 | 19 | 0.000 |
Why?
|
| Rosette Formation | 1 | 1980 | 152 | 0.000 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1986 | 974 | 0.000 |
Why?
|
| Constriction, Pathologic | 1 | 1983 | 1096 | 0.000 |
Why?
|
| Monocytes | 1 | 1988 | 2570 | 0.000 |
Why?
|
| Immunoglobulin A | 1 | 1982 | 978 | 0.000 |
Why?
|
| Airway Obstruction | 1 | 1983 | 661 | 0.000 |
Why?
|
| Lymphatic System | 1 | 1979 | 254 | 0.000 |
Why?
|
| Respiratory Function Tests | 1 | 1982 | 1682 | 0.000 |
Why?
|
| Immunoglobulin E | 1 | 1982 | 1502 | 0.000 |
Why?
|
| Genetic Linkage | 1 | 1981 | 2341 | 0.000 |
Why?
|
| New England | 1 | 1979 | 1054 | 0.000 |
Why?
|
| Mass Spectrometry | 1 | 1983 | 2192 | 0.000 |
Why?
|
| Pedigree | 1 | 1981 | 4542 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1981 | 6345 | 0.000 |
Why?
|
| Genotype | 1 | 1981 | 12990 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1986 | 11742 | 0.000 |
Why?
|